loader image
Saturday, October 18, 2025
88.1 F
McAllen
- Advertisement -

Human Polyclonal Antibody to Treat Unvaccinated Non-Hospitalized Adult Patients

Translate to Spanish or other 102 languages!

Enrollment in this study is voluntary and the patients will not be charged for this treatment and/or the follow-up. Image for illustration purposes.
Enrollment in this study is voluntary and the patients will not be charged for this treatment and/or the follow-up. Image for illustration purposes.

Mega Doctor News

- Advertisement -

EDINBURG, Texas – DHR Health is involved in a new and innovative study to use human polyclonal antibody to treat non-hospitalized patients who are >18 years of age with mild-moderate COVID-19. Safety of this human polyclonal antibody (SAB-185) has already been established. This would be the first such study in which human polyclonal antibodies will be used to treat patients with COVID-19.

“We are embarking on a new study that is FDA-approved and NIH-funded to infuse human polyclonal antibodies in non-hospitalized unvaccinated high-risk individuals who are COVID-19 positive” said Sohail Rao, MD, MA, DPhil, President & CEO, DHR Health Institute for Research & Development. “The human polyclonal antibody has been shown to neutralize both wild-type and various variants of SARS-CoV-2 virus including Delta. the primary objective of this study is to prevent hospitalization of the patients with COVID-19.”

The study entails a single treatment with either REGEN-COV monoclonal antibody or SAB-185 human polyclonal antibody which is infused intravenously. Enrollment in this study is voluntary and the patients will not be charged for this treatment and/or the follow-up. To learn more about who would qualify for this treatment, please visit this weblink: https://youtu.be/u8lubUkucNY or call COVID-19 treatment hotline (956) 362-2393 (9:00 a.m. – 5:00 p.m.; M-F) or (956) 342-2383 for more information.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

The Human Bean’s “Coffee for a Cure” to Benefit The Renaissance Cancer Foundation, Oct. 17th

The Human Bean located at 1124 E. Nolana in McAllen is inviting coffee-lovers to "drink pink" on October 17 for their annual “Coffee for a Cure” breast cancer giveback event. All food and beverage proceeds on that day will benefit the Renaissance Cancer Foundation, marking The Human Bean’s largest fundraiser of the year.

2025 DHR Health Fashion Show & Gala Honoring Heroic Patients

The Edinburg Conference Center at Renaissance was filled with emotion, gratitude, and hope on Wednesday, October 15, 2025, as DHR Health hosted its 2025 Fashion Show & Gala Honoring Heroic Patients. The annual event celebrated breast cancer survivors and highlighted the importance of breast reconstruction awareness, education, and innovation in women’s health care.

The Harmful Effects of Alcohol on the Brain

Millions of people drink alcohol, and while many may know the harm it can cause to their liver, some may be surprised to know it can be just as damaging to the brain.

STC’s Chapa Turns Curiosity into Purpose

At just 19-years-old, STC Psychological Science student Gianna Chapa has already built a foundation for her future that reflects both determination and heart.
- Advertisement -
×